Navigation Links
Industry And FDA Leaders To Discuss The Evolving Science Of Cardiovascular Safety (CV) And Diabetic Drug Development
Date:7/29/2009

The Drug Information Association (DIA) will host a two-day workshop on Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications from September 23-24, 2009 in Washington, DC.

Horsham, PA, (PRWEB) July 29, 2009 -- The Drug Information Association (DIA) will host a two-day workshop on Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications from September 23-24, 2009 in Washington, DC.

The workshop will examine evolving scientific data surrounding CV safety and diabetic drug development, future methods to make development of these drugs more streamlined while ensuring safety. Session topics will include:

 
  • Type 2 Diabetes: Clinical implications, CV manifestations, and epidemiology
  • Therapies and targets for treatment of Diabetes Mellitus - potential implications on CV safety
  • Glycemic control - evidence for positive and negative impacts on CV and renal outcomes in Type 2 DM
  • New trial design approaches to assessing CV safety
  • Clinical evidence that T2DM diabetic drugs can increase CV risk
  • Diabetic drug development and CV safety
  • Approaches to clinical analysis of CV risk
  • Novel clinical trial approaches
  • Future approaches to assessing T2DM drug development and CV safety
  • QT experience as a model for furthering collaborative approaches/research in CV

"Recent data published in major medical journals suggests possible increase in cardiovascular (CV) risk associated with the use of certain drugs for the treatment of type 2 diabetes (T2DM)," explains Program Chair Philip T. Sager, MD, FACC, Vice President, Clinical Research, Cardiopulmonary and Metabolic Clinical Development, Gilead Sciences, Inc. "As a result, the Division of Metabolism and Endocrinology Products of the US Food and Drug Administration (FDA) issued a new guidance in December 2008 recommending that all new T2DM drugs demonstrate CV safety in appropriately designed and powered outcome studies."

About the Drug Information Association (DIA):

DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:

Joe Krasowski
Drug Information Association
215-293-5812
www.diahome.org

###

Read the full story at http://www.prweb.com/releases/dia/cv_diabetes_workshop/prweb2687594.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. EDI Health Group Continues to Drive Growth of EDI Processing Services in the Dental Healthcare Industry Through Addition of 25 New Connections in the First Half of 2009
2. Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board
3. Career Step Launches New Exam Prep Course for Medical Transcription Industry Credential
4. Nexicon Technology to Protect Healthcare Industry
5. Kirby Lesters New KL60: The Pharmacy Industrys First and Only Compact, Fully-Automated Dispensing System
6. Giant Bud Banner Half the Size of Football Field Flies Sunday Protesting Hydroponics Industry Cartel Monopoly that's Harming California's Medical Marijuana Patients
7. The Ensign Group Announces Appointment of Healthcare Industry Leader to Board of Directors
8. THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT Highlights the Burgeoning Demographics of Orthopaedics and the Continuing Health of the Industry
9. Claricode Launches Medical Software Scholarship Program with a Notable Judging Panel of Industry Experts
10. Career Step Partners with Computer Learning Center to Help Students Gain Careers in Growing Healthcare Industry
11. Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinsons Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Industry And FDA Leaders To Discuss The Evolving Science Of Cardiovascular Safety (CV) And Diabetic Drug Development 
(Date:10/13/2017)... Pa. (PRWEB) , ... October 13, 2017 , ... While ... dark poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. ... to medication in darkness or restricted lighting. As such, it eliminates the need to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an update ... Puerto Rico , where the company manufactures ... Following a comprehensive onsite assessment, the ... temporary loss of power and minimal water damage due ... have resumed, and the company expects to return to ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology: